Nephro Care India IPO: Risk or Reward? 💰 | Nephro Care India IPO Review | Apply or Not?

Nephro Care India IPO opens for subscription on June 28, 2024 and closes on July 2, 2024. Should you invest in Nephro Care India IPO or avoid it? In this Nephro Care India IPO review we will cover points like financial performance, brand reach, future growth, valuation and much more! If you enjoyed our Nephro Care India IPO analysis video, please subscribe to us!

About Nephro Care India Limited:

Nephro Care India is a leading treatment center in Kolkata specializing in kidney care. Their team of experienced doctors and modern facilities provide a comprehensive approach to treating kidney disease. They offer a variety of services, from medication and lifestyle changes to advanced radiology and even kidney transplants. Nephro Care India goes beyond just physical health, focusing on the mental and emotional well-being of their patients for holistic care.

Additional Nephro Care India IPO Details:

Nephro Care India IPO price band is set at ₹85 to ₹90 per share. The minimum lot size for an application is 1600 Shares. The minimum amount of investment required by retail investors is ₹144,000. The minimum lot size investment for HNI is 2 lots (3,200 shares) amounting to ₹288,000.

Join Us For all the latest updates about startups, preipo and unicorns.

Keep yourself updated with the market situation.

Join us on Facebook​

LinkedIN​

Twitter​

Instagram​

Telegram​

Contact us at +91 7065560002 via Whatsapp/Normal call

Or Mail us at help@planify.in

⬇️ Download the app for easy access. Links are given below:

​Planify iPhone App​

​Planify Android App